文献速递复苏、休克与脓毒症创伤与烧伤重症综合管理与镇静镇痛

老年创伤患者中复苏性主动脉腔内球囊阻断是否禁忌:AAST AORTA登记分析

Is Resuscitative Endovascular Balloon Occlusion of the Aorta contraindicated in the elderly? An analysis of the American Association for the Surgery of Trauma Aortic Occlusion for Resuscitation in Trauma and Acute Care Surgery registry.
PubMed 文献 · J Trauma Acute Care Surg · 2025-04-02
一句话结论65岁及以上无脉或持续心脏骤停的创伤患者中,REBOA与复苏性开胸相比院内死亡率无显著差异,但轻微并发症更多;作者认为REBOA是可行的替代方案,尚需进一步研究优化患者选择与技术。

该回顾性队列分析利用Aortic Occlusion for Resuscitation in Trauma and Acute Care Surgery登记(2013—2024年),纳入在创伤抢救室评估时无脉或持续心脏骤停、有主动脉阻断指征的65岁及以上创伤患者360例(RT 162例,REBOA 198例),分组依据医生自行选择的主动脉阻断方式。REBOA组止血控制存活率更高(75.8% vs 49.4%,p<0.001),总体院内死亡率更低(74.6% vs 97.5%,p<0.001),主要并发症相似,轻微并发症更多(34.7% vs 6.3%,p<0.001)。校正混杂因素后,死亡率(OR 1.14;95%CI 0.34-1.79;p=0.702)和主要并发症(OR 0.87;95%CI 0.62-1.87;p=0.596)均无差异,REBOA与轻微并发症风险升高相关(OR 1.25;95%CI 1.01-2.29;p=0.007)。作者结论认为REBOA在老年创伤患者中提供与RT相当的生存和主要并发症结局,轻微并发症风险增加,是可行的替代方案,但需进一步研究优化患者选择和技术。

要点

  • 65岁及以上无脉或持续心脏骤停的创伤患者中,REBOA组止血控制存活率为75.8%,RT组为49.4%(p<0.001)。
  • REBOA组总体院内死亡率为74.6%,RT组为97.5%(p<0.001);校正混杂因素后死亡率无差异(OR 1.14;95%CI 0.34-1.79;p=0.702)。
  • 主要并发症两组相似(校正OR 0.87;95%CI 0.62-1.87;p=0.596),轻微并发症REBOA更多(34.7% vs 6.3%,p<0.001;校正OR 1.25;95%CI 1.01-2.29;p=0.007)。
  • 作者认为REBOA是RT的可行替代方案,但需进一步研究优化患者选择和技术。
  • 证据等级:治疗/管理,Level III。

适用人群与场景

  • 65岁及以上创伤患者,在创伤抢救室评估时无脉或持续心脏骤停、有主动脉阻断指征。
  • 分组依据医生自行选择的主动脉阻断方式(REBOA或RT)。

研究设计与关键结果

  • 研究类型:回顾性队列分析,使用Aortic Occlusion for Resuscitation in Trauma and Acute Care Surgery登记(2013—2024年),共纳入360例患者(RT 162例,REBOA 198例)。
  • 主要结局:止血控制存活率REBOA组75.8% vs RT组49.4%(p<0.001);总体院内死亡率REBOA组74.6% vs RT组97.5%(p<0.001)。
  • 校正混杂因素(穿透伤、损伤严重度评分>15、收缩压<90 mm Hg、心率>100次/分、格拉斯哥昏迷评分<9、提供者类型、需止血控制操作)后:死亡率OR 1.14(95%CI 0.34-1.79;p=0.702),主要并发症OR 0.87(95%CI 0.62-1.87;p=0.596),均无显著差异。
  • 轻微并发症REBOA组34.7% vs RT组6.3%(p<0.001);校正后REBOA与轻微并发症风险升高相关(OR 1.25;95%CI 1.01-2.29;p=0.007)。

证据类型、等级与局限

  • 证据类型:回顾性队列分析(基于登记数据)。
  • 证据等级:治疗/管理;Level III。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在65岁及以上无脉或持续心脏骤停的创伤患者中,医生选择REBOA与选择RT相比,校正后死亡率和主要并发症无显著差异,但REBOA组轻微并发症更多。
  • 作者认为REBOA是RT的可行替代方案,但需进一步研究优化患者选择和技术;原文未给出具体患者选择标准或技术优化建议。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Resuscitative endovascular balloon occlusion of the aorta (REBOA) has emerged as a critical tool in trauma management, particularly for elderly patients. However, its application in this population is often debated because of concerns over potential complications. This study evaluates the outcomes of REBOA compared with resuscitative thoracotomy (RT) in trauma patients 65 years or older with indications for aortic occlusion.

METHODS: A retrospective cohort analysis was conducted using the Aortic Occlusion for Resuscitation in Trauma and Acute Care Surgery registry (2013-2024), including trauma patients presented pulseless or sustained cardiac arrest in the trauma bay during evaluation. Patients were divided into REBOA and RT groups based on the aortic occlusion method selected at physician discretion. Variables analyzed included demographics, injury severity, hemorrhage control procedures, transfusion needs, and clinical outcomes. Multivariate analyses accounted for confounders, such as penetrating injuries, Injury Severity Score of >15, systolic blood pressure of <90 mm Hg, heart rate of >100 beats per minute, Glasgow Coma Scale score of <9, provider type, and the need for hemorrhage control procedures.

RESULTS: The study included 360 patients (RT, 162; REBOA, 198). Survival to hemorrhage control was significantly higher in the REBOA group (75.8% vs. 49.4%, p < 0.001), and overall, in-hospital mortality was lower (74.6% vs. 97.5%, p < 0.001). Major complications were similar between groups, but minor complications occurred more frequently in the REBOA cohort (34.7% vs. 6.3%, p < 0.001). Adjusted analyses revealed no differences in mortality (odds ratio [OR], 1.14; 95% confidence interval [CI], 0.34-1.79; p = 0.702) or major complications (OR, 0.87; 95% CI, 0.62-1.87; p = 0.596), while REBOA was associated with higher odds of minor complications (OR, 1.25; 95% CI, 1.01-2.29; p = 0.007).

CONCLUSION: Resuscitative endovascular balloon occlusion of the aorta provides comparable survival and major complication outcomes to RT in elderly trauma patients, with an increased risk of minor complications. These results suggest that REBOA is a viable alternative to RT, although further studies are needed to optimize patient selection and procedural techniques.

LEVEL OF EVIDENCE: Therapeutic/Care Management; Level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Henry R, Lammers D, Clegg A, et al. Is Resuscitative Endovascular Balloon Occlusion of the Aorta contraindicated in the elderly? An analysis of the American Association for the Surgery of Trauma Aortic Occlusion for Resuscitation in Trauma and Acute Care Surgery registry. J Trauma Acute Care Surg. 2025. PMID: 40170237. doi:10.1097/TA.0000000000004617

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。